Wakamoto Pharmaceutical Co (TSE:4512) Days Sales Outstanding : 117.74 (As of Dec. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Wakamoto Pharmaceutical Co Days Sales Outstanding?

Wakamoto Pharmaceutical Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円2,539 Mil. Wakamoto Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円1,968 Mil. Hence, Wakamoto Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 117.74.

The historical rank and industry rank for Wakamoto Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4512' s Days Sales Outstanding Range Over the Past 10 Years
Min: 112.35 Med: 117.34 Max: 151.04
Current: 126.51

During the past 13 years, Wakamoto Pharmaceutical Co's highest Days Sales Outstanding was 151.04. The lowest was 112.35. And the median was 117.34.

TSE:4512's Days Sales Outstanding is ranked worse than
84.67% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.69 vs TSE:4512: 126.51

Wakamoto Pharmaceutical Co's Days Sales Outstanding increased from Dec. 2022 (108.93) to Dec. 2023 (117.74).

Wakamoto Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Wakamoto Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wakamoto Pharmaceutical Co Days Sales Outstanding Chart

Wakamoto Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

121.20

112.35

116.52

114.62

123.51

Wakamoto Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															108.93	116.71	142.87	132.08	117.74

Competitive Comparison of Wakamoto Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Wakamoto Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wakamoto Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wakamoto Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Wakamoto Pharmaceutical Co's Days Sales Outstanding falls into.

Wakamoto Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Wakamoto Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (2664.597	+	3196.694)	/	2 )	/	8660.377	*	365
=	2930.6455					/	8660.377	*	365
=	123.51

Wakamoto Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2460.522	+	2618.318)	/	2 )	/	1968.011	*	365 / 4
=	2539.42					/	1968.011	*	365 / 4
=	117.74

Wakamoto Pharmaceutical Co (TSE:4512) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Wakamoto Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Wakamoto Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Wakamoto Pharmaceutical Co (TSE:4512) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wakamoto Pharmaceutical Co Ltd (TSE:4512) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-2, Nihonbashi Honcho, Chuo-ku, Tokyo, JPN, 103-8330

Website

http://www.wakamoto-pharm.co.jp

Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.

Wakamoto Pharmaceutical Co (TSE:4512) Headlines

No Headlines